Futura Medical PLC
23 February 2004
Futura Medical Plc
Additional Listing
Futura Medical plc ('Futura'), the AIM-quoted pharmaceutical and medical device
group that develops innovative products for the sexual healthcare market, is
issuing further shares pursuant to the exercise of the second of three call
options, as announced on 5 February 2004, under the subscription agreement with
Long Fleet Systems Inc signed in June 2003.
Today Futura issued 87,658 shares and Application has been made for the new
shares being issued to be admitted to trading on AIM. The new shares will rank
pari passu with existing ordinary shares and dealings are expected to commence
at 8.00am on 24 February 2004. This issue will raise £62,325 for Futura.
This completes all tranches of issues of shares in accordance with the second
call option.
As noted in the announcement on 5 February 2004 in respect of completion of all
tranches, warrants will be issued over 250,000 ordinary shares exercisable at
any time over the next 12 months at an exercise price of 71.10 pence per
ordinary share in accordance with the subscription agreement with Long Fleet
Systems Inc.
James Barder, Chief Executive of Futura Medical, said: 'We are pleased to have
completed this second round of additional funding, which sets us on an even
firmer footing in building a successful pharmaceutical and medical device group
to serve the growing sexual healthcare market.'
For further information:
Futura Medical plc
James Barder, Chief Executive Tel: +44 (0) 1483 845 670
mailto:james.barder@futuramedical.co.uk www.futuramedical.co.uk
------------------------------------------ --------------------------
Media enquiries:
Bankside
Peter Curtain / Alex Tweed Tel: +44 (0) 20 7444 4140
mailto:alexandra.tweed@bankside.com www.bankside.com
------------------------------------- --------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.